On August 6, 2024, a research team of ten from Pingdingshan Federation of Industry and Commerce, led by comrade Ren, a member of the Party Group and Vice Chairman of the Federation, came to Henan EMICRO Microbial Medicine Co., Ltd. for work research. Vice Chairman of Xinxiang Federation of Industry and Commerce, General Manager of Xinxiang Wangshi Group, Chairman of EMICRO Biomedicine Company, Wang Yuqiao, General Manager of EMICRO Biomedicine Company, Li Wei, Deputy General Manager Jin Jianxin, Financing Manager Cao Chenghua and other leaders attended the reception and discussion.

　　Jin Jianxin, Deputy General Manager of EMICRO Biomedicine Company, introduced the research and development status, progress, advantages, and prospects of the company's "1.1 class anti-tumor innovative drug BTK inhibitor TM471 project" through an electronic screen, as well as the difficulties and demands currently faced. The attendees had cordial discussions and practical exchanges on topics such as "enhancing new quality productivity" and "the current situation of innovative drug industry and minimally invasive new drugs", discussing the bright prospects for the development of innovative drugs in Henan Province. Wang Yuqiao, Chairman of EMICRO Biomedicine Company, stated that the business associations of the two regions should strengthen exchanges and learning, make good use of policies, resources, and intellectual advantages to provide assistance and support for the development of local enterprises, especially innovative enterprises, and create a favorable development environment.